H-group (homology)
5070.1 14 kDa protein of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase)
Ligands and drugs
368
Member domains
219
with ligand contacts (≤ 4 Å)
59.5% of members
126
with DrugDomain annotations
34.2% of members
115
with a DrugBank compound
31.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5070.1 belongs to X-group 5070 14 kDa protein of cytochrome bc1 complex (Ubiquinol-cytochrome c reductase), which has 11 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03429 | CDL | Tetrastearoyl cardiolipin | 112 |
| DB04327 | PEE | Phosphatidylethanolamine | 28 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 6 |
| DB09114 | PCF | Colfosceril palmitate | 6 |
| DB08690 | UQ2 | Ubiquinone Q2 | 2 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 1 |
| DB04799 | — | 6-Hydroxy-5-undecyl-4,7-benzothiazoledione | 1 |
| DB07401 | — | Azoxystrobin | 1 |
| DB07636 | — | 5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione | 1 |
| DB07763 | — | (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE | 1 |
| DB07778 | — | (S)-famoxadone | 1 |
| DB08330 | — | METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE | 1 |
| DB08453 | — | 2-Nonyl-4-quinolinol 1-oxide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CDL | CARDIOLIPIN | 194 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 51 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 38 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 30 |
| CN3 | (2R,5S,11R,14R)-5,8,11-trihydroxy-2-(nonanoyloxy)-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate | 15 |
| 8PE | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate | 14 |
| PEF | DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE | 10 |
| PCF | 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE | 6 |
| CN6 | (2R,5R,11S,14R)-2-(butanoyloxy)-5,8,11-trihydroxy-5,11-dioxido-16-oxo-14-[(propanoyloxy)methyl]-4,6,10,12,15-pentaoxa-5,11-diphosphanonadec-1-yl undecanoate | 2 |
| PC7 | (7S)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 2 |
| PGT | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 2 |
| UNL | Unknown ligand | 2 |
| 3PH | 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE | 1 |
| LOP | (1R)-2-{[(R)-(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(DODECANOYLOXY)METHYL]ETHYL (9Z)-OCTADEC-9-ENOATE | 1 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 1 |
| UQ2 | UBIQUINONE-2 | 1 |